se of Virechana and Punaranvadi niruha basti in stage I and stage II of Chronic kidney disease.
- Conditions
- Health Condition 1: N182- Chronic kidney disease, stage 2 (mild)
- Registration Number
- CTRI/2019/12/022317
- Lead Sponsor
- J S AYURVED MAHAVIDYALAYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
1. Patients fulfilling the diagnostic criteria.
2. Patients having age between 18 to 65 years of both gender will be included for the study.
3. Patients having serum creatinine level less than 3.0 mg/dl.
4. Patients indicated for Virechana and Basti.
1. Female patients having pregnancy, breast feeding or post-delivery period.
2. Patients of end stage renal disease
3. Patients who are on dialysis treatment from more than 1 month period. Patients who are already operated for renal transplantation and then having nephropathy.
4. Patients of hepato-renal insufficiency or renal insufficiency due to haemodynemic circulatory disorders and CCF.
5. Patients with some serious illness like cardio-vascular diseases, psychological disorders, serious acute organic diseases, serious chronic co-morbidities, hypo or hyper thyroidism, liver or metabolic disorders etc.
6. Patients on renal replacement therapy.
7. Patients with bleeding piles or any other bleeding disorders.
8. Patients contraindicated for Virechana and Basti.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method otify improvement in signs and symptoms and laboratory investigations <br/ ><br>in the patientsTimepoint: The outcome will be assessed after 56 days of <br/ ><br>treatment in comparison to before treatment <br/ ><br>measures <br/ ><br>in the patients
- Secondary Outcome Measures
Name Time Method ILTimepoint: NOT APPLICABLE